Skip to main navigation Skip to search Skip to main content

β-sitosterol inhibits the growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle

  • Atif B. Awad
  • , Rebecca L. Von Holtz
  • , Jessie P. Cone
  • , Carol S. Fink
  • , Ying Chen Chen
  • SUNY Buffalo

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Abstract

The present study examined the SM cycle as a mechanism to explain the inhibitory effect of SIT on HT-29 cell growth. SIT was the main phytosterol in the diet. Supplementation of SIT at 16 μM for 5 days in the media inhibited growth by 55% as compared to cholesterol. SIT supplementation had no effect on sphingosine production. Ceramide production increased 45% with SIT supplementation as compared to cholesterol. Sterol supplementation had no effect on phospholipase C, a key enzyme in the PKC pathway. We concluded that the activation of the SM cycle may play a role in growth inhibition of HT-29 cells by SIT.

Original languageEnglish
Pages (from-to)471-473
Number of pages3
JournalAnticancer Research
Volume18
Issue number1 A
StatePublished - Jan 1998

Keywords

  • Ceramide phospholipase C
  • Phytosterols
  • Sphingomyelin
  • Sphingosine
  • β-sitosterol

Fingerprint

Dive into the research topics of 'β-sitosterol inhibits the growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle'. Together they form a unique fingerprint.

Cite this